Globus Medical Inc financial data

Symbol
GMED on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
2560 General Armistead Avenue, Audubon, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 245 % -54.1%
Quick Ratio 91.1 % -56.8%
Debt-to-equity 25.6 % +13.7%
Return On Equity 2.55 % -37.4%
Return On Assets 2.03 % -38.9%
Operating Margin 6.59 % -22.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 138M shares +1.84%
Entity Public Float 7.7B USD +67.4%
Weighted Average Number of Shares Outstanding, Basic 136M shares +20%
Weighted Average Number of Shares Outstanding, Diluted 138M shares +20.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.52B USD +60.6%
Research and Development Expense 164M USD +32%
Operating Income (Loss) 166M USD +24.7%
Nonoperating Income (Expense) 8.93M USD +319%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 121M USD -27%
Income Tax Expense (Benefit) 17.7M USD -58.3%
Net Income (Loss) Attributable to Parent 103M USD -16.2%
Earnings Per Share, Basic 0.76 USD/shares -30.3%
Earnings Per Share, Diluted 0.75 USD/shares -29.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 106M USD +109%
Accounts Receivable, after Allowance for Credit Loss, Current 558M USD +10.8%
Inventory, Net 659M USD -22.3%
Assets, Current 2.18B USD +13.7%
Deferred Income Tax Assets, Net 94.2M USD +782%
Property, Plant and Equipment, Net 562M USD -4.26%
Operating Lease, Right-of-Use Asset 49.6M USD -17.2%
Intangible Assets, Net (Excluding Goodwill) 795M USD -14%
Goodwill 1.43B USD -0.15%
Other Assets, Noncurrent 75.1M USD -4.45%
Assets 5.25B USD +3.26%
Accounts Payable, Current 75.1M USD +32.6%
Employee-related Liabilities, Current 152M USD +7.81%
Accrued Liabilities, Current 261M USD +8.37%
Liabilities, Current 856M USD +118%
Deferred Income Tax Liabilities, Net 23.9M USD -71.7%
Operating Lease, Liability, Noncurrent 83.6M USD -8.18%
Other Liabilities, Noncurrent 21.5M USD -12.5%
Liabilities 1.07B USD -1.26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.86M USD +32.7%
Retained Earnings (Accumulated Deficit) 1.15B USD +1.37%
Stockholders' Equity Attributable to Parent 4.18B USD +4.49%
Liabilities and Equity 5.25B USD +3.26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 52.4M USD -1.74%
Net Cash Provided by (Used in) Financing Activities -116M USD -4036%
Net Cash Provided by (Used in) Investing Activities -46.6M USD -524%
Common Stock, Shares Authorized 775M shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -113M USD -268%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 784M USD +67.9%
Deferred Tax Assets, Valuation Allowance 183M USD -4.28%
Deferred Tax Assets, Gross 460M USD +15.3%
Operating Lease, Liability 93.8M USD -8.9%
Depreciation 135M USD +43.7%
Payments to Acquire Property, Plant, and Equipment 28.6M USD +78.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 106M USD -22.6%
Lessee, Operating Lease, Liability, to be Paid 130M USD -9.99%
Property, Plant and Equipment, Gross 1.11B USD +9.39%
Operating Lease, Liability, Current 10.2M USD -14.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.7M USD -1.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.3M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure -48.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 36.1M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.4M USD -0.23%
Unrecognized Tax Benefits 56.4M USD +67%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.5M USD -6.52%
Operating Lease, Payments 4.76M USD +611%
Additional Paid in Capital 3.03B USD +5.59%
Amortization of Intangible Assets 119M USD +134%
Depreciation, Depletion and Amortization 55.3M USD +205%
Deferred Tax Assets, Net of Valuation Allowance 277M USD +33.2%
Share-based Payment Arrangement, Expense 54.2M USD +39%